Zweig-DiMenna Associates’s Profound Medical PROF Stock Holding History

Zweig-DiMenna Associates’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-130,000	Closed	-$1.02M	–	91
2025 Q4	$1.02M	Buy	+130,000	New	+$835K	0.06%	104
2024 Q2	–	Sell	-104,261	Closed	-$889K	–	116
2024 Q1	$889K	Sell	104,261 -26,356	-20%	-$220K	0.08%	109
2023 Q4	$1.11M	Buy	130,617 +43,343	+50%	+$412K	0.13%	92
2023 Q3	$890K	Sell	87,274 -37,305	-30%	-$387K	0.11%	99
2023 Q2	$1.62M	Sell	124,579 -86,196	-41%	-$1.07M	0.2%	90
2023 Q1	$1.96M	Sell	210,775 -85,892	-29%	-$994K	0.27%	79
2022 Q4	$3.23M	Buy	296,667 +31,000	+12%	+$169K	0.47%	69
2022 Q3	$1.07M	Buy	265,667 +9,500	+4%	+$64.1K	0.23%	70
2022 Q2	$1.87M	Buy	256,167 +14,500	+6%	+$115K	0.35%	73
2022 Q1	$2.17M	Buy	241,667 +7,500	+3%	+$72.2K	0.29%	78
2021 Q4	$2.63M	Buy	234,167 +12,500	+6%	+$156K	0.21%	93
2021 Q3	$3.25M	Hold	221,667	–	–	0.23%	107
2021 Q2	$3.63M	Buy	221,667 +40,078	+22%	+$746K	0.22%	114
2021 Q1	$3.66M	Sell	181,589 -1,000	-0.5%	-$24K	0.25%	109
2020 Q4	$3.75M	Buy	182,589 +64,500	+55%	+$1.19M	0.24%	101
2020 Q3	$2.08M	Sell	118,089 -69,000	-37%	-$1.1M	0.14%	113
2020 Q2	$3.17M	Buy	+187,089	New	+$2.36M	0.33%	82

Other funds holding PROF

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $395M AUM

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Zweig-DiMenna Associates's PROF Position: Q1 2026 in Review

Zweig-DiMenna Associates sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 130,000 shares — an estimated $1.02M sold.

Zweig-DiMenna Associates first reported a position in PROF in Q2 2020 and held it in 17 quarters. The position peaked at $3.75M in Q4 2020. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

Zweig-DiMenna Associates reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
Zweig-DiMenna Associates sold 130,000 Profound Medical shares in Q1 2026, an estimated $1.02M.
Zweig-DiMenna Associates first reported a position in Profound Medical in Q2 2020 and held it in 17 quarters.
Zweig-DiMenna Associates's Profound Medical position peaked at $3.75M in Q4 2020.
57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2026, filed 5 May 2026.